RKDA
Arcadia Biosciences, Inc.
NASDAQ · Basic Materials · Agricultural Inputs · US
$0.47
+0.23%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.7M | 4.9M | 5.0M | 4.5M | 7.4M |
| Cost of Revenue | 3.1M | 3.1M | 3.0M | 2.2M | 6.1M |
| Gross Profit | 1.6M | 1.8M | 2.1M | 2.3M | 1.3M |
| Operating Expenses | |||||
| R&D Expense | — | 9.0K | 53.0K | 64.0K | 1.5M |
| SG&A Expense | 5.4M | 7.0M | 9.6M | 8.2M | 15.0M |
| General & Admin Expense | 1.1M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 257.0K | 4.7M | (4.0M) | 84.0K | (1.2M) |
| Total Operating Expenses | 5.7M | 11.8M | 5.7M | 8.4M | 15.3M |
| Cost and Expenses | 8.8M | 14.9M | 8.7M | 10.6M | 21.4M |
| Operating Income (EBIT) | (4.1M) | (10.0M) | (3.6M) | (6.1M) | (14.0M) |
| Non-Operating | |||||
| Interest Income | 14.0K | 221.0K | 782.0K | 695.0K | 289.0K |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 14.0K | 221.0K | 782.0K | 695.0K | 289.0K |
| Other Non-Op Income/Expense | (7.1M) | 7.7M | (661.0K) | 781.0K | 3.2M |
| Non-Operating Income (excl Interest) | 7.1M | (7.7M) | 4.0M | (84.0K) | 1.2M |
| EBT (Pre-Tax Income) | (11.1M) | (2.3M) | (4.3M) | (5.3M) | (10.8M) |
| Income Tax Expense | 8.0K | 8.0K | 8.0K | 8.0K | 14.0K |
| Bottom Line | |||||
| Net Income | (11.1M) | (2.3M) | (7.0M) | (14.0M) | (15.4M) |
| Earnings from Cont. Ops | (11.1M) | (2.3M) | (4.3M) | (5.3M) | (10.8M) |
| Earnings from Discont. Ops | — | — | (2.7M) | (8.7M) | (4.8M) |
| Bottom Line Net Income | (11.1M) | (2.3M) | (7.0M) | (14.0M) | (15.4M) |
| Per Share | |||||
| Basic EPS | ($8.14) | ($1.71) | ($5.16) | ($11.30) | ($26.05) |
| Diluted EPS | ($8.15) | ($1.71) | ($5.16) | ($11.30) | ($26.05) |
| Revenue Per Share | $3.47 | $3.55 | $3.70 | $3.60 | $12.38 |
| Shares | |||||
| Basic Shares Outstanding | 1.4M | 1.4M | 1.4M | 1.2M | 599389 |
| Diluted Shares Outstanding | 1.4M | 1.4M | 1.4M | 1.2M | 599389 |
| Profitability Metrics | |||||
| EBITDA | (11.1M) | (2.3M) | (7.5M) | (5.7M) | (14.7M) |
| D&A | 12.0K | 32.0K | 113.0K | 287.0K | 479.0K |
| EBIT | (11.1M) | (2.3M) | (7.6M) | (6.0M) | (15.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026